According to Acumen Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ0.90. In 2022 the company made an earnings per share (EPS) of -ยฃ0.83 an increase over its 2021 EPS that were of -ยฃ2.12.